Biosearch Technologies Licenses H1N1 Flu IP from CDC | GenomeWeb

NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed H1N1 influenza signatures and the influenza A sub-typing panel signatures from the US Centers for Disease Control and Prevention.

Biosearch, based in Novato, Calif., said it is the first to license the CDC influenza signatures. The license grants Biosearch rights under the CDC patents to manufacture and sell oligonucleotides bearing the H1N1 and influenza A sub-typing signatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.